Overview Submission Instructions Recent Publications Frequently Asked Questions Research Topics

Looking to publish in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal focused on the discovery, development, and validation of assays, instruments, and technologies that support accurate detection of dementia across forms and stages, with particular emphasis on dementia biomarkers, disease prevention, risk factors, and healthcare disparities. The journal aims to address important clinical and research problems in Alzheimer's disease and related dementias and is limited to human studies.

Looking to publish in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now

Subject Clinical Neurology, Neurosciences

Impact Factor 4.4

Quartile Q1

Open Access Type Open

eISSN 2352-8729

Invitation Only No

Cost Range APC: $2,670 USD / £1,940 GBP / €2,180 EUR; Policy Forum and Short Report: $971 USD / £706 GBP / €793 EUR; waived for Editorial, Erratum, Invited Commentary, Letter to the Editor, and Perspective.

Submission Instructions

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter Cover Letter requirements are not specified.

Abstract Review Articles must include an abstract. Abstract should be approximately 150 words.

Manuscript Manuscript must not exceed 10,000 words excluding the abstract, references, figures, and tables. Manuscript must include a Research in Context section with the subheadings systematic review, interpretation, and future directions. Manuscript must include keywords, a competing interests statement, mandatory highlights of 3 to 5 bullet points in a separate editable file, and an AI use disclosure in the Methods or Acknowledgments section if applicable.

References References are limited to a maximum of 60. References must use Vancouver style. Reference numbers must be indicated in square brackets in the text, and the first six authors in each reference should be listed followed by et al.

Figures & Tables A maximum of six figures, boxes, or tables is permitted. All figures and tables must be uploaded with their accompanying captions or titles and related descriptive information.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Research Articles

Cover Letter Cover Letter requirements are not specified.

Abstract A structured abstract is required for Research Articles. Abstract must not exceed 150 words. Abstract must be structured in IMRAD format. Abstract must use the uppercase headings INTRODUCTION, METHODS, RESULTS, and DISCUSSION followed by a colon and space.

Manuscript Manuscript must not exceed 3,500 words excluding the abstract, references, figures, and tables. Manuscript must include Background, Methods, Results, Discussion, References, Acknowledgements/Conflicts/Funding Sources, Key Words, and a Research in Context section. Manuscript must include keywords, a Research in Context section of 150 words or less with the subheadings systematic review, interpretation, and future directions, mandatory highlights of 3 to 5 bullet points, and an AI use disclosure in the Methods or Acknowledgments section if applicable.

References References are limited to a maximum of 50. References must use Vancouver style. References must be cited in the text using square-bracketed numbers and list the first six authors followed by et al.

Figures & Tables A maximum of six figures, boxes, or tables is permitted. All figures and tables must be uploaded as files with their accompanying captions, titles, descriptions, or footnotes. Figure and table citations in the text must match the files provided.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Short Reports

Cover Letter Cover Letter requirements are not specified.

Abstract An abstract is required for Short Reports. The abstract must not exceed 150 words. The abstract must be structured. The abstract must include the headings Introduction, Methods, Results, and Discussion.

Manuscript The manuscript must not exceed 1,500 words excluding the abstract, references, figures, and tables. The manuscript must use IMRAD format with the headings INTRODUCTION, METHODS, RESULTS, and DISCUSSION in uppercase followed by a colon and space. The manuscript must include a Research in Context section, keywords, highlights of 3 to 5 bullet points, a competing interests statement, and disclosure of any AI-assisted technologies used in the Methods or Acknowledgments section.

References Short Reports may include a maximum of 20 references. References must use Vancouver style. Reference numbers must be cited in square brackets in the text and the first six authors in each reference should be listed followed by "et al.".

Figures & Tables Short Reports may include no more than two figures, boxes, or tables. All figures and all tables must be uploaded separately with their accompanying captions or titles, descriptions, and footnotes. Figure and table citations in the text must match the files provided.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.

Abstract Abstract requirements are not specified.

Manuscript Letters to the Editor must not exceed 750 words. Letters to the Editor must relate to the content of earlier issues of the journal. The manuscript must include a Research in Context section of 150 words or less with the subheadings systematic review, interpretation, and future directions, include keywords and a competing interests statement, submit 3 to 5 highlights in a separate editable file, and disclose any AI-assisted manuscript development in the Methods or Acknowledgments section.

References Letters to the Editor may include a maximum of 10 references. References must use Vancouver style. Reference numbers must be indicated in square brackets in the text, every cited reference must appear in the reference list, and the first six authors should be listed followed by et al.

Figures & Tables Letters to the Editor may include no more than one figure. Figures and tables must be uploaded as files with their captions, titles, descriptions, and footnotes rather than relying only on in-text placement.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Recent Publications

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease

Diana Esteller‐Gauxax, Núria Guillén, Neus Falgàs, Beatriz Bosch, Adrià Tort‐Merino, Sergi Borrego‐Écija, Roger Puey, Raquel Ruiz‐Garcia, Laura Naranjo, Aida Niñerola‐Baizán, Andrés Perissinotti, Núria Bargalló, Anna Antonell, Albert Lladó, Raquel Sánchez‐Valle, Agnès Pérez‐Millan, Mircea Balasa

10.1002/dad2.70347

View Publication

Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment

Truc Tran Thanh Nguyen, Yu‐Ling Chang

10.1002/dad2.70345

View Publication

Automated analysis of expressive prosody in Dutch patients with behavioral variant frontotemporal dementia and primary progressive aphasia

Lize C. Jiskoot, Olaiya Aro, Liset de Boer, Jackie M. Poos, Julie F. H. De Houwer, Tine Swartenbroekx, Elise G. P. Dopper, Esther van den Berg, Harro Seelaar

10.1002/dad2.70346

View Publication

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study

Chloe A. Krakauer, Luke Reilly, Yu‐Ru Su, Rod L. Walker, Dana Lee, Vilaipone A. Xaiyamuangchanh, David J. Cronkite, Nicole M. Gatto, Paul K. Crane, Emily Y. Chew, David E. Arterburn, Cecilia S. Lee

10.1002/dad2.70368

View Publication

From clinical trial to clinical experience: Lecanemab therapy in a real‐world case series

Michael Sonson, Golnaz Yadollahikales, Allison Flores, Ilana Lasner, Susan Lee, Zaldy Tan, Christina Quach, Sarah Kremen

10.1002/dad2.70365

View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 26 days, median submission to acceptance is 117 days, and median acceptance to publication is 35 days.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Is a cover letter required?

A submission letter should include the names, mailing addresses, phone and fax numbers, and e-mail addresses of 5-7 potential reviewers with appropriate expertise.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

What are the publication costs?

APC for accepted articles is $2,670 USD / £1,940 GBP / €2,180 EUR. Policy Forum and Short Report are $971 USD / £706 GBP / €793 EUR. The APC is waived for Editorial, Erratum, Invited Commentary, Letter to the Editor, and Perspective. There are no submission fees or page charges.

Reformat to Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring using Livewrite Premium

Research Topics

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Functional Brain Connectivity Studies Traumatic Brain Injury Research Intracerebral and Subarachnoid Hemorrhage Research Cancer-related cognitive impairment studies Intensive Care Unit Cognitive Disorders Neurological Disease Mechanisms and Treatments Down syndrome and intellectual disability research Frailty in Older Adults Neurobiology of Language and Bilingualism Glaucoma and retinal disorders Advanced Neuroimaging Techniques and Applications Older Adults Driving Studies Cerebrospinal fluid and hydrocephalus Retinal Imaging and Analysis Health, Environment, Cognitive Aging Cognitive Functions and Memory Amyotrophic Lateral Sclerosis Research Parkinson's Disease Mechanisms and Treatments Schizophrenia research and treatment Neuroinflammation and Neurodegeneration Mechanisms Health disparities and outcomes Nutritional Studies and Diet Memory and Neural Mechanisms

Related Journals

Lancet Elsevier BV

Colloids And Surfaces B-biointerfaces Elsevier BV

Comprehensive Psychiatry Elsevier BV

Journal Of Functional Foods Elsevier BV

Jaad International Elsevier BV

Journal Of Parkinsons Disease IOS PRESS